MAPT and Alzheimer disease: Moreover, individuals with primary age-related tauopathy, who exhibited equivalent tau burdens but negligible amounts of Aβ, had lesser high-molecular-weight (HMW) tau levels than patients with AD, who showed typical Aβ-plaque and tau-tangle burden (Bennett et al., 2017).